Skip to content
News
Firebrick secures strategic investment from Philippines partner

Firebrick secures strategic investment from Philippines partner


Firebrick Pharma (ASX:FRE) is pleased to announce that it has secured an investment of A$1.1 million from Pharma Nutria N.A., Inc. (PNAI), an entity that is part of the SV More Group of Companies, which includes the Company’s Philippines licensing partner, SV More Pharma Corporation. Under the $1.1 million investment, PNAI is acquiring 11,578,947 ordinary…

New agreement allows Nasodine launch in Philippines

New agreement allows Nasodine launch in Philippines


Firebrick Pharma is pleased to announce that it has executed an amended agreement with its existing marketing partner in the Philippines, S.V. More Pharma Corporation (SV More). Under the amended agreement, SV More will have the right to manufacture Nasodine® Nasal Spray (“Nasodine”) in the Philippines, rather than import the product from Australia. This will…